Driehaus Capital Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-616,220
| Closed | -$4.02M | – | 440 |
|
|
2024
Q2 | $4.02M | Buy |
616,220
+218,302
| +55% | +$1.42M | 0.04% | 270 |
|
|
2024
Q1 | $3.3M | Sell |
397,918
-195,084
| -33% | -$1.62M | 0.03% | 290 |
|
|
2023
Q4 | $6.53M | Hold |
593,002
| – | – | 0.08% | 258 |
|
|
2023
Q3 | $4.99M | Hold |
593,002
| – | – | 0.06% | 282 |
|
|
2023
Q2 | $7.45M | Sell |
593,002
-989,249
| -63% | -$12.4M | 0.09% | 249 |
|
|
2023
Q1 | $26.1M | Sell |
1,582,251
-36,102
| -2% | -$595K | 0.37% | 80 |
|
|
2022
Q4 | $24.2M | Sell |
1,618,353
-1,349,092
| -45% | -$20.2M | 0.36% | 88 |
|
|
2022
Q3 | $66.4M | Sell |
2,967,445
-125,281
| -4% | -$2.8M | 1.01% | 16 |
|
|
2022
Q2 | $51.8M | Sell |
3,092,726
-957,962
| -24% | -$16M | 0.84% | 20 |
|
|
2022
Q1 | $121M | Buy |
4,050,688
+16,332
| +0.4% | +$489K | 1.49% | 3 |
|
|
2021
Q4 | $124M | Buy |
4,034,356
+983,654
| +32% | +$30.2M | 1.26% | 5 |
|
|
2021
Q3 | $96.2M | Buy |
3,050,702
+196,662
| +7% | +$6.2M | 1.14% | 9 |
|
|
2021
Q2 | $104M | Buy |
2,854,040
+311,421
| +12% | +$11.4M | 1.38% | 6 |
|
|
2021
Q1 | $87.9M | Buy |
2,542,619
+1,446,339
| +132% | +$50M | 1.3% | 8 |
|
|
2020
Q4 | $45.6M | Buy |
1,096,280
+23,271
| +2% | +$967K | 0.74% | 28 |
|
|
2020
Q3 | $45.7M | Buy |
+1,073,009
| New | +$45.7M | 0.94% | 16 |
|